Trends in tuberculosis notification and mortality and factors associated with treatment outcomes in Serbia, 2005 to 2015.
Adolescent
Adult
Age Distribution
Aged
Aged, 80 and over
Antitubercular Agents
/ therapeutic use
Child
Child, Preschool
Disease Notification
/ statistics & numerical data
Educational Status
Female
Humans
Infant
Infant, Newborn
Male
Middle Aged
Mortality
/ trends
Serbia
/ epidemiology
Sex Distribution
Treatment Outcome
Tuberculosis, Pulmonary
/ drug therapy
Serbia
Tuberculosis
factors
mortality
notification
treatment outcomes
Journal
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
ISSN: 1560-7917
Titre abrégé: Euro Surveill
Pays: Sweden
ID NLM: 100887452
Informations de publication
Date de publication:
01 2020
01 2020
Historique:
entrez:
16
1
2020
pubmed:
16
1
2020
medline:
28
8
2020
Statut:
ppublish
Résumé
BackgroundPreviously a country with medium tuberculosis (TB) burden, Serbia almost reached a low TB burden during the period 2005 to 2015.AimThe aim of this study was to analyse the trends in notification rates and treatment success rates as well as to identify predictors of treatment outcomes.MethodsWe performed a trend analysis and logistic regression analysis of 17,441 TB cases registered from 2005 to 2015 in all health facilities in Serbia, to identify predictors of treatment success, loss to follow-up and mortality.ResultsFrom 2005 to 2015, TB notification rate and mortality in Serbia decreased but treatment success remained below the global target. Loss to follow-up was associated with retreatment (odds ratio (OR) = 2.38; 95% confidence interval (CI): 2.08-2.77), male sex (OR = 1.57; 95% CI: 1.39-1.79), age younger than 65 years (OR = 1.37; 95% CI: 1.20-1.51), lower education level (OR = 2.57; 95% CI: 1.74-3.80) and pulmonary TB (OR = 1.28; 95% CI: 1.06-1.56). Deaths were more frequent in retreatment cases (OR = 1.39; 95% CI: 1.12-1.61), male patients (OR = 1.34; 95% CI: 1.19-1.52), those 65 years and older (OR = 4.34; 95% CI: 4.00-5.00), those with lower education level (OR = 1.63; 95% CI: 1.14-2.33) and pulmonary TB (OR = 2.24; 95% CI: 1.78-2.83).ConclusionsSpecial interventions should be implemented to address groups at risk of poor treatment outcome.
Identifiants
pubmed: 31937395
doi: 10.2807/1560-7917.ES.2020.25.1.1900322
pmc: PMC6961260
doi:
Substances chimiques
Antitubercular Agents
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
Int J Tuberc Lung Dis. 1998 Feb;2(2):96-104
pubmed: 9562118
Int J Tuberc Lung Dis. 2000 Jan;4(1):32-5
pubmed: 10654641
Epidemiol Infect. 2013 Jun;141(6):1223-31
pubmed: 22846385
BMC Public Health. 2011 Feb 28;11:140
pubmed: 21356062
Clin Infect Dis. 2004 Jan 15;38(2):199-205
pubmed: 14699451
Lancet. 2012 Dec 15;380(9859):2224-60
pubmed: 23245609
Euro Surveill. 2017 Feb 23;22(8):
pubmed: 28251890
Croat Med J. 2008 Dec;49(6):807-12
pubmed: 19090606
PLoS One. 2010 Apr 06;5(4):e10043
pubmed: 20386611
Tuber Lung Dis. 1996 Oct;77(5):391-400
pubmed: 8959141
Public Health Action. 2015 Sep 21;5(3):194-201
pubmed: 26399291
BMC Public Health. 2018 Sep 12;18(1):1114
pubmed: 30208864
PLoS One. 2018 Dec 26;13(12):e0209098
pubmed: 30586448
PLoS One. 2014 Dec 02;9(12):e114225
pubmed: 25460363
Int J STD AIDS. 2016 Nov;27(13):1204-1212
pubmed: 26482328
BMC Public Health. 2015 Oct 09;15:1040
pubmed: 26452646
Int J Tuberc Lung Dis. 2007 Jun;11(6):647-51
pubmed: 17519096
Cent Eur J Public Health. 2019 Jun;27(2):99-105
pubmed: 31241283
Euro Surveill. 2015;20(49):null
pubmed: 26676247
Euro Surveill. 2013 Mar 21;18(12):null
pubmed: 23557946